Pharmafile Logo
Pharmafocus logo
Advanced Search

Cervarix

Showing 9 posts of 9 posts found.

Votrient image

GSK seeks licence extensions

August 8, 2013
Sales and Marketing Cervarix, EMA, GSK, Votrient

GlaxoSmithKline is seeking to extend the licences of two of its brands, Cervarix and Votrient, in a bid to extend …

News
Astrazeneca image

AstraZeneca’s Fluenz chosen for wider flu immunisation

July 26, 2012
Sales and Marketing AZ, AstraZeneca, Cervarix, Gardasil, Lansley, MedImmune

The UK has chosen AstraZeneca’s Fluenz to extend the country’s flu vaccination programme. The health secretary Andrew Lansley said that …

News
Gardasil picture

UK government drops Cervarix for Gardasil

November 28, 2011
Sales and Marketing Cervarix, GSK, Gardasil, MSD, Sanofi

The UK government has performed a U-turn on its HPV vaccine programme by favouring Sanofi and MSD’s Gardasil over GlaxoSmithKline’s …

News
Gardasil

Gardasil better value for money than Cervarix, finds new study

September 28, 2011
Sales and Marketing Cervarix, Gardasil, HPV, cervical cancer

A new report by the Health Protection Agency has found that Gardasil is a more cost-effective vaccine for cervical cancer …

News

UK hails high uptake of cervical cancer vaccine

January 31, 2011
Research and Development Cervarix, HPV

The NHS campaign to vaccinate girls against the future risk of developing cervical cancer has been a success, according to …

News

GSK’s Cervarix finally wins US approval

October 19, 2009
Sales and Marketing Cervarix, GSK, US

US regulator the FDA has approved GlaxoSmithKline's cervical cancer vaccine Cervarix, finally allowing the company to bring it to the …

News

Cervarix not to blame for UK post-vaccination death

October 5, 2009
Sales and Marketing Cervarix, NHS, reg, vaccines

The death of a 14-year-old girl who died shortly after having received a cervical cancer vaccine was caused by an …

News

GSK faces fresh US delays over Cervarix

September 30, 2009
Sales and Marketing Cervarix, GSK, vaccines

GSK faces new delays in the US over the approval of its cervical cancer vaccine Cervarix, after the FDA failed …

News

WHO gives Cervarix green light for use in developing nations

July 10, 2009
Research and Development, Sales and Marketing Cervarix, vaccines

News
The Gateway to Local Adoption Series

Latest content

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026